Difficulty: Medium
Average Score: 81%
Practice
You are seeing a new patient to the practice. The patient is 66 years old and is on metoprolol XL for management of PSVT and HCTZ for her blood pressure. She states she has been thirstier lately and wonders if that has something to do with her HCTZ. As a part of your work up you order a ÔÇÿgeneral health panelÔÇÖ. The patientÔÇÖs fasting glucose is 157, creatinine is 1.0, and her TSH is 3.0. Based on her symptoms and her lab results she is diagnosed with type 2 diabetes. With your knowledge of pharmacodynamics and pharmacotherapeutics, you recognize there is a need for a change in her current medications due to which of the following?
Correct answer
B
Rationale
The correct answer is B) Diuretics and beta blockers decrease insulin sensitivity.
Explanation:
- Both HCTZ (a diuretic) and metoprolol (a beta blocker) have been associated with decreasing insulin sensitivity, which can lead to impaired glucose control and potentially contribute to the development or exacerbation of type 2 diabetes.
- Diuretics can cause electrolyte imbalances and increase blood glucose levels, while beta blockers can mask hypoglycemic symptoms, making it harder to detect and manage diabetes effectively.
Why others are wrong:
A) Diuretics and beta blockers do not increase insulin sensitivity; in fact, they have the opposite effect.
C) Beta blockers are not known to cause renal nephropathy directly; their impact on renal function is more related to their hemodynamic effects.
D) Beta blockers do not cause peripheral neuropathy; this condition is commonly associated with conditions like diabetes, not beta blockers.
Educational context:
Understanding the pharmacodynamics and pharmacotherapeutics of medications commonly used in the management of chronic conditions like hypertension is crucial for healthcare providers. Recognizing the potential effects of these medications on glucose metabolism and overall health is essential for making informed decisions about treatment strategies, especially in patients at risk for or with existing diabetes.
Explanation:
- Both HCTZ (a diuretic) and metoprolol (a beta blocker) have been associated with decreasing insulin sensitivity, which can lead to impaired glucose control and potentially contribute to the development or exacerbation of type 2 diabetes.
- Diuretics can cause electrolyte imbalances and increase blood glucose levels, while beta blockers can mask hypoglycemic symptoms, making it harder to detect and manage diabetes effectively.
Why others are wrong:
A) Diuretics and beta blockers do not increase insulin sensitivity; in fact, they have the opposite effect.
C) Beta blockers are not known to cause renal nephropathy directly; their impact on renal function is more related to their hemodynamic effects.
D) Beta blockers do not cause peripheral neuropathy; this condition is commonly associated with conditions like diabetes, not beta blockers.
Educational context:
Understanding the pharmacodynamics and pharmacotherapeutics of medications commonly used in the management of chronic conditions like hypertension is crucial for healthcare providers. Recognizing the potential effects of these medications on glucose metabolism and overall health is essential for making informed decisions about treatment strategies, especially in patients at risk for or with existing diabetes.